Sanofi Long-Term Concentrated

Location: Paris, France

CIK: 0001121404 · Show all filings

Period: Q4 2024 (Next →)

Filing Date: Feb 14, 2025

Total Value: $174M (100.0% shares, 0.0% debt)

Holdings (9)

MGTX MeiraGTx Holdings plc 42.6%

Value $74.28M Shares 12,197,737 Est. Cost $5.86 Unrealized 0.0%

NVAX Novavax 31.7%

Value $55.32M Shares 6,880,481 Est. Cost $9.64 Unrealized 0.0%

INBX Inhibrx Biosciences, Inc. 10.2%

Value $17.83M Shares 1,157,926 Est. Cost $15.23 Unrealized 0.0%

ANAB AnaptysBio 6.2%

Value $10.88M Shares 821,917 Est. Cost $24.22 Unrealized 0.0%

— IGM Biosciences 5.0%

Value $8.792M Shares 1,438,975 Est. Cost $6.11 Unrealized —

ELDN Eledon 1.9%

Value $3.358M Shares 814,980 Est. Cost $3.94 Unrealized 0.0%

— LAVA Therapeutics N.V. 1.0%

Value $1.825M Shares 1,919,455 Est. Cost $0.95 Unrealized —

— Inozyme, Inc 0.7%

Value $1.228M Shares 443,255 Est. Cost $2.77 Unrealized —

QTTB Q32 Bio Inc. 0.5%

Value $840K Shares 244,083 Est. Cost $31.58 Unrealized 0.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
MGTX	MeiraGTx Holdings plc	12,197,737	$74.28M	42.6%	$5.86	0.0%	COM	G59665102
NVAX	Novavax	6,880,481	$55.32M	31.7%	$9.64	0.0%	COM NEW	670002401
INBX	Inhibrx Biosciences, Inc.	1,157,926	$17.83M	10.2%	$15.23	0.0%	COM	45720N103
ANAB	AnaptysBio	821,917	$10.88M	6.2%	$24.22	0.0%	COM	032724106
—	IGM Biosciences	1,438,975	$8.792M	5.0%	$6.11	—	COM	449585108
ELDN	Eledon	814,980	$3.358M	1.9%	$3.94	0.0%	COM	28617K101
—	LAVA Therapeutics N.V.	1,919,455	$1.825M	1.0%	$0.95	—	SHS	N51517105
—	Inozyme, Inc	443,255	$1.228M	0.7%	$2.77	—	COM	45790W108
QTTB	Q32 Bio Inc.	244,083	$840K	0.5%	$31.58	0.0%	COM	746964105